The thioredoxin/glutaredoxin family consists of small heat-stable proteins that have a highly conserved CXXC active site and that participate in the regulation of many redox reactions. We have searched the human genome sequence to find putative pseudogenes (non-functional copies of protein-coding genes) for all known members of this family. This survey has resulted in the identification of seven processed pseudogenes for human Trx1 and two more for human Grx1. No evidence for the presence of processed pseudogenes has been found for the remaining members of this family. In addition, we have been unable to detect any non-processed pseudogenes derived from any member of the family in the human genome. The seven thioredoxin pseudogenes can be divided into two groups: Trx1-ψ2, -ψ3, -ψ4, -ψ5 and -ψ6 arose from the functional ancestor, whereas Trx1-ψ1 and -ψ7 originated from Trx1-ψ2 and -ψ6, respectively. In all cases, the pseudogenes originated after the human/rodent radiation as shown by phylogenetic analysis. This is also the case for Grx1-ψ1 and Grx1-ψ2, which are placed between rodent and human sequences in the phylogenetic tree. Our study provides a molecular record of the recent evolution of these two genes in the hominid lineage.
Introduction
Thioredoxins (Trx) and glutaredoxins (Grx) comprise a family of ubiquitous small heat-stable proteins that function as general protein-disulfide reductases by the reversible oxidation of their respective active sites, viz. CGPC for thioredoxin and CPYC or CSYC for glutaredoxin (Holmgren 1989; Lundberg et al. 2001) . Both proteins catalyze different redox reactions at the expense of the reducing power of NADPH, but by different pathways as shown in Scheme 1:
Scheme 1
Thus, the thioredoxin system transfers the electrons from NADPH to flavoenzyme thioredoxin reductase (TrxR), which, in turn, keeps thioredoxin in its active reduced form. In contrast, in the glutaredoxin system, the electrons are sequentially transferred to glutathione reductase (GR), glutathione (GSH) and glutaredoxin (Holmgren 1989) . This model, which has remained unaltered since the discovery of Trx and Grx in Escherichia coli, has received an unexpected input with the striking discovery that, in Drosophila, glutathione is maintained in its reduced form by a thioredoxin system because the fruitfly lacks the enzyme glutathione reductase (Kanzok et al. 2001) .
Thioredoxin and glutaredoxin are present in all organisms investigated, from lower prokaryota to humans, and have been highly conserved throughout evolution. Many different functions have been ascribed to thioredoxin and Giannis Spyrou · William Wilson · C. Alicia Padilla · Arne Holmgren · Antonio Miranda-Vizuete glutaredoxin since their discovery as electron donors for the essential enzyme ribonucleotide reductase in E. coli (Holmgren 1976; Laurent et al. 1964) . Some other functions are also shared by these two proteins, including electron donor for 3'-phosphoadenosine 5'-phosphosulfate reductase, modulator of transcription factor DNA-binding activity and general antioxidant defense (Hirota et al. 2000; Holmgren 1989 Holmgren , 2000 . However, there are roles that either Trx or Grx specifically carry out. For instance, mammalian Trx1 is secreted by cells, is able to act as a co-cytokine and regulate apoptosis by direct interaction with ASK1 protein (Nakamura et al. 1997; Saitoh et al. 1998) , in addition to specifically reducing methionine sulfoxide reductase (Arner and Holmgren 2000) . In bacteria, Trx1 is the only electron donor for methionine sulfoxide reductase (similar to mammals) and participates in phage assembly, whereas Trx2 has been shown to maintain the reducing environment of E.coli cytoplasm (Arner and Holmgren 2000; Stewart et al. 1998) . Such functions are not shared by any of the known glutaredoxins. On the other hand, only glutaredoxin is known to display dehydroascorbic acid reductase activity, which is necessary for the neutrophil oxidative burst during infection (Park and Levine 1996) and to regulate HIV-1 protease in vivo (Davis et al. 1997) .
During the last few years, we have been deeply involved in the identification and characterization of novel members of the thioredoxin/glutaredoxin family. This search has resulted in a complicated picture, as more than one thioredoxin or glutaredoxin form can be found within the same organism. Thus, E. coli contains two thioredoxins and three glutaredoxins (Åslund et al. 1994; Laurent et al. 1964; Miranda-Vizuete et al. 1997a) ; yeast has two thioredoxin systems, in cytosol and mitochondria respectively, and two glutaredoxins (Grant 2001; Pedrajas et al. 1999) . Photosynthetic organisms have several thioredoxin systems in different cellular compartments, including chloroplasts; these systems have been implicated in light energy transduction and response to oxidative stress (Juttner et al. 2000; Mestres-Ortega and Meyer 1999) and more recently in the control of the plant self-incompatibility response (Cabrillac et al. 2001) . Finally, mammalian cells have at least two thioredoxin and glutaredoxin systems located in the cytosol and mitochondria, respectively (Holmgren 1989; Lundberg et al. 2001; and other thioredoxin-like proteins have been identified (Miranda-Vizuete et al. 1998; A. Miranda-Vizuete et al., unpublished results) . In addition, we have recently characterized the first member of the thioredoxin family with a tissue-specific distribution in human spermatozoa .
In order to complete the study of all the sequences originating from human thioredoxin and glutaredoxin genes, we report here the outcome of a survey for putative pseudogenes of all known members of this family in the human genome. This search has resulted in the identification of seven human Trx1 and two Grx1 pseudogenes, all of them falling into the category of processed pseudogenes.
Materials and methods

Sequence identification and chromosomal localization
All known human thioredoxin and glutaredoxin protein sequences were compared with the non-redundant and high-throughput data set of the human genome draft (in six-frame translation) at NCBI by using the TBLASTN search (TBLAST hits showing at least 80% identity and with e-values ≤0.001 along the whole protein sequence were considered as sequence matches and selected for further analysis). All the identified sequences were searched against the UniSTS database (http://www.ncbi.nlm.nih.gov/genome/sts/ epcr.cgi), which integrates marker and mapping data from public resources, in order to assign them to their corresponding interval chromosomal markers. With this information, we mapped their chromosomal localization under the option of physical maps by using the GenBank and ideogram option for display settings.
Sequence alignment and phylogenetic analysis
The DNA sequences were aligned by using the Clustal W program (Thompson et al. 1994 ). The phylogenetic analysis was produced by applying the neighbour-joining method of Saitou and Nei (1987) to the alignment data. Both the Clustal W alignment and neighbour-joining algorithm were implemented by using the Megalign program included in the DNASTAR Software Package (DNASTAR, Madison, Wis.). Statistical support for nodes of the neighbourjoining trees was assessed by using the 50% majority-rule consensus trees compiled from 1000 bootstrap replications (Felsenstein 1985) implemented with the NJPlot Program available at http://www.biom3.univ-lyon1.fr/pub/mol_phylogeny/njplot/. To root the tree, we used the human Sptrx thioredoxin domain and the human mitochondrial Grx2 mature form (resulting after cleavage of the mitochondrial targeting sequence), respectively (Lundberg et al. 2001; . The degree of divergence (or evolutionary distance) between each pseudogenes and its functional homologue was estimated by the number of transitions and transversions per site between the two sequences by using the Jukes-Cantor correction for mutation saturation formula d=-(3/4)ln (1-(4/3)p) where p is the number of substitutions (Graur and Li 2000) . The sequence of the processed pseudogene used for these calculations was that corresponding to the open reading frame (ORF) of the functional gene. The time of the retrotransposition event was calculated assuming a constant mutation rate of 1×10 -9 per site/year (Nachman and Crowell 2000) .
Results and discussion
The human genome draft has been recently published in a joint effort from both public and private initiatives. The first surprise came with respect to the determination of the total number of genes, as the initial estimate of 70,000-100,000 genes (Fields et al. 1994 ) dramatically dropped to 30,000-40,000 protein coding genes, viz. only about twice as many as in Caenorhabditis elegans or Drosophila. However, alternative splicing of a vast majority of these genes is expected to increase the number of functional protein products (Lander et al. 2001; Venter et al. 2001) . In humans, coding information comprises less than 5% of the genome, whereas more than 50% is embraced by repetitive sequences, most of them being derived from transposable elements (Lander et al. 2001) . The availability of the human genome sequence provides an invaluable tool for discovering new genes. With the identification of the complete set of human genes and proteins, we will radically transform our understanding of all aspects of human biology and medicine. This approach is nevertheless hampered by the presence, within the genome, of inactive sequences, the so-called pseudogenes, with high identity to one or more paralogous functional genes. Pseudogenes are a small but significant part of genomic repetitive sequences and are present in all groups of living organisms. Pseudogenes arise from a functional gene by two different mechanisms: (1) by retrotransposition from its mRNA, generating a processed pseudogene as they lack introns or (2) by genomic DNA duplication resulting in a non-processed pseudogene that retains the genomic organization of the ancestral gene (Mighell et al. 2000) . In both cases, the inactivation of the new copy is considered to occur shortly after integration in the genome. Although most pseudogenes are inactive because of their inability to be transcribed, there is a growing number of reported pseudogenes that are transcribed (driven by nearby promoter-like sequences), although no evidence of translated products has been found so far. The functional relevance of these transcripts remains unclear (Brosius 1999) .
To gain further insights into the thioredoxin/glutaredoxin field, we have conducted a survey in the human genome sequence to identify the putative pseudogenes for any known member of the thioredoxin/glutaredoxin family. The discrimination between functional and non-functional copies of different members of a protein family based solely on sequence data must be undertaken carefully as it is possible that the expression analysis might not have been performed in the appropriate cell, tissue or developmental stage.
We assumed the following criteria when considering a given genomic sequence a pseudogene: (1) high identity (higher than 80%, e-value≤0.001) at the nucleotide level with the paralogous gene; (2) unanimity between the sequence present in human public (NCBI) and private (Celera) databases; (3) the presence of coding disablement events, such as premature stop codons in frame, deletions/insertions leading to frameshifts, removal of the starting methionine or active site and insertion of repetitive sequences; (4) no matches of the sequence with any entry in the expressed sequence tag (EST) database. On this basis, we initiated our study of the protein sequence of each known member of the human thioredoxin/glutaredoxin family in order to search for sequences with homology at the DNA level in the human genome draft in both non-redundant and high-throughput human databases. Using this method, we identified several homologous sequences. The first filtering step was to remove from this set all sequences that coded for any of the known functional genes. The remaining sequences were considered as either potential pseudogenes or potential novel functional members of the protein family. We rapidly ruled out the possibility that any of the selected sequences would encode a functional novel member of the thioredoxin/gluta- Fig. 2 (continued) redoxin family as all of them presented clear disablement features and no matches with the EST database were found. Two pseudogenes for thioredoxin-1 and one more for glutaredoxin-1 (Tonissen and Wells 1991; MirandaVizuete and Spyrou 2000, 2001 ) have previously been reported and were present among the selected sequences, further supporting our search strategy. Therefore, we initially hypothesized that all the sequences obtained by this approach were potential pseudogenes.
The selected sequences were subsequently aligned at the DNA level with the complete mRNA of their respective functional genes. The alignment results indicated seven potential pseudogenes for human Trx1 and two for Grx1 but none for the remaining members of the family, viz. Trx2 and Grx2 (both mitochondrial), Txl (cytosolic) and Sptrx (sperm specific; Lundberg et al. 2001; MirandaVizuete et al. 1997b MirandaVizuete et al. , 1998 MirandaVizuete et al. , 2001 . It is important to note that all the sequences matched their corresponding functional gene along the full mRNA sequence length, except for three cases of Alu insertions that, when removed from the sequence, also resulted in full mRNA homology (Trx1-ψ2, -ψ6 and -ψ7) and one 5'-truncation (Trx1-ψ7), strongly supporting the idea that they might be processed pseudogenes. We confirmed, in the Celera database, all disablement events and that no single EST entry matched their sequences. Taken together, we concluded that the nine sequences identified were processed pseudogenes.
The features of the seven identified Trx1 pseudogenes are summarized in Table 1 and Fig. 1 . Trx1-ψ1 and Trx1-ψ2 have been previously described (Miranda-Vizuete and Spyrou 2000; Tonissen and Wells 1991), whereas Trx1-ψ3 through Trx1-ψ7 are new and have been numbered in decreasing order of homology with the functional Trx1 gene. In addition, in order to visualize the disablement differences between the Trx1 gene and its processed pseudogenes, we have aligned their corresponding sequences with that of the Trx1 ORF (Fig. 2) . All Trx1 pseudogenes harbor many different types of disablement mutations (including Alu sequence insertions) resulting in a sequence that, if translated, would render a truncated defective protein.
Apart from the lack of introns and disablement mutations, processed pseudogenes have other features, such as an imperfect polyA tail at the point where the homology with the functional gene ceases, flanking repeats thought to be involved in the retrotransposition event and the absence of promoter regulatory regions (Mighell et al. 2000) . We looked for these additional characteristics in the thioredoxin pseudogenes. For example, an imperfect polyA tail or at least a stretch of adenosine residues was found in all pseudogenes, immediately after the point where the homology with Trx1 mRNA ceased (not shown). Moreover, the promoter regions described in the Trx1 gene (TATA box and SP1 site; Kaghad et al. 1994) were absent in all pseudogenes as homology finished at different positions within the Trx1 5'-untranslated region (UTR), except for the 5'-truncation in Trx1-ψ7. Another characteristic of processed pseudogenes is that they usually map at chromosomes different from the functional paralogue, in contrast to non-processed pseudogenes that arise from genomic duplication and therefore map within the same chromosomal region. As shown in Table 1 , Trx1 is located at chromosome 9q31, whereas all Trx1 pseudogenes map in different chromosomes. However, it has been difficult to identify the flanking repeats in some of the pseudogenes; this might be attributable to accumulation of additional mutations in this area, although Trx1-ψ1 and Trx1-ψ2 repeats have been previously reported (MirandaVizuete and Spyrou 2000; Tonissen and Wells 1991) . Finally, it should be noted that only Trx1-ψ7 presents a 5'-truncation, which is assumed to arise from abortive arrest during the reverse transcription process (Ophir and Graur 1997) . This truncation would remove the first 44 residues of the putative protein plus any 5'-UTR sequences. Trx1-ψ1 and Trx1-ψ4 also have small 5'-truncations of 47 and 35 bp respectively, compared with Trx1 cDNA (Fig. 1) .
With regard to human Grx1, we have found two processed pseudogenes, one of which has previously been reported (Miranda-Vizuete and Spyrou 2001). Before the characterization of these Grx1 pseudogenes is described, it is important to comment on the presence of different Grx1 mRNA sequences. To date, two entries for the complete Grx1 cDNA sequence have been deposited in the NCBI database: a longer form of 1328 nucleotides (Park and Levine 1996 ; NM_002064 originally derived from entry AF069668) and a shorter form of 837 nucleotides (Padilla et al. 1995; X76648) . Both forms differ only in the length of their respective 3'-UTRs. A comparison of both sequences with the genomic clone AC008821, which contains the complete human glutaredoxin gene, allowed us to determine the nature of this discrepancy, which results from the use of two distinct splicing acceptor sites for the third exon; the differences between the two forms are thus explained, as the intron2/exon3 boundary lies within the 3'-UTR (Fig. 3) . This finding is in agreement with the genomic sequence for the human Grx1 gene previously reported (Park and Levine 1997) , although the absence of the intronic sequences in the paper of Park and Levine (1997) would not have allowed this conclusion. A search with both Grx1 cDNA sequences in the EST database (which can be used as an estimation of the relative abundance of any given mRNA) found that the two forms are expressed, although a much higher proportion of the sequences are derived from the shorter form (data not shown).
Despite its lower expression, both human Grx1 pseudogenes Grx1-ψ1 and Grx1-ψ2 are clearly derived from the longer form. Similarly to the Trx1 pseudogenes, Grx1-ψ1 and Grx1-ψ2 are processed pseudogenes with multiple disablement features, including frameshifts, removal of the active site and stop codons in frame (Table 2, Fig. 4) . They also have in common with Trx1 pseudogenes the lack of any regulatory sequence similar to the ones described for the functional gene (Park and Levine 1997) , viz. the presence of an imperfect polyA tail and a chromosomal localization at different positions from the functional paralogue (Table 2) . Indeed, a Southern blot analysis performed on human genomic DNA identified not only the functional Grx1 gene at chromosome 5, but also other Grx-like sequences in chromosomes 12 and 14 (Padilla et al. 1996) . Grx1-ψ2 maps at position 14q32.13-32.2 suggesting that it might be one of these.
The presence of pseudogenes within the human genome should be viewed in a wider context of a dynamic evolutionary process driven by retrotransposition. As previously mentioned, approximately half of the human genome consists of repeated sequences of various types, with most of them arising from reverse transcription from RNA (Baltimore 2001; Lander et al. 2001 ). Retrotransposition not only generates non-functional pseudogenes, but also new functional forms that evolve differently from the ancestral gene once they have integrated in the genome and become transcriptionally active (Brosius 1999) . Indeed, the thioredoxin family has such an example in the intron-less Sptrx gene that codes for a sperm-specific protein .
Pseudogenes are important for evolutionary studies because their pattern of mutation is assumed to be neutral as they are not subject to functional constraints (Harrison et al. 2001) . This has allowed the calculation of the rate of nucleotide substitutions, insertions and deletions in genomic DNA (Gojobori et al. 1982; Nachman and Crowell 2000; Ophir and Graur 1997) or the determination of the rates of genomic loss for an organism . To gain further insights into the evolution of the thioredoxin/glutaredoxin genes in the mammalian lineage, we performed a phylogenetic analysis to determine the origin of the identified pseudogenes. Figure 5A shows the phylogenetic tree of all human Trx1 pseudogenes that arose after the hominid/rodent radiation. From this analysis, two different Trx1 pseudogene groups can be distinguished: group 1 includes which arose from the functional hominid Trx1 gene, and group 2, which is composed of Trx1-ψ1 and -ψ7 and which originated from the Trx1-ψ2 and -ψ6 pseudogenes, respectively. This is inferred from the position of the pair Trx1-ψ1/-ψ2 and Trx1-ψ6/-ψ7 in the same tree branch and the shorter 5'-sequences of Trx1-ψ1 and Trx1-ψ7. We also conclude that the Alu insertion in Trx1-ψ2 occurred after the duplication event.
The phylogenetic analysis for Grx1 pseudogenes is simpler, as both Grx1-ψ1 and Grx1-ψ2 arose from the longer form of Grx1 mRNA by a retrotransposition event (Fig. 5B) . There is an apparent contradiction regarding the position of the pig Grx1 gene, which would be expected to be located between human and rodent genes. Pig Grx1 protein displays important changes in its sequence compared with the rest of the mammalian glutaredoxins sequenced to date, including a residue change at the active site, which might explain its anomalous tree location (Yang et al. 1989 ).
435 Fig. 3 Genomic and mRNA organization of human Grx1. The sequences of the splice acceptor sites are shown for the shorter (above exon-3 box) and longer (underneath exon-3 box) Grx1 mRNA forms. Middle shadowed box Exon-3 box, white boxes Grx1 ORF, shadowed boxes Grx1 UTRs The age of a processed pseudogene (time since retrotransposition) can be estimated by the divergence between its sequence from that of the functional gene measured as nucleotide substitutions, assuming a constant rate of 1× 10 -9 substitutions per site per year (Nachman and Crowell 2000) . Figure 5 also shows the evolutionary distance be-436 Fig. 4 Sequence alignment of human Grx1 ORF with the corresponding region of human Grx1 pseudogenes. Differences at the nucleotide level are shadowed. Major disablement features (see Table 2 ) are boxed. The sequence of the active site is shown in bold tween the human pseudogenes and their corresponding functional paralogues. For human Trx1 pseudogenes, the divergence score matches well with the phylogenetic analysis, although Trx1-ψ5, -ψ6 and -ψ7 have a significantly higher score than the rest of the thioredoxin pseudogenes and the human/rodent radiation estimated to have occurred about 85 million years ago (Friedberg and Rhoads 2000) . This can be explained by the involvement of additional factors others than evolutionary time, such as locus insertion, which could have had a significant influence in their evolution (Mighell et al. 2000; . Thus, pseudogene sequences may have detrimental position effects on the expression of nearby genes or they may be mutagenic through homologous DNA interactions with their functional counterparts (Wu and Morris 1999) . In these cases, more drastic mutations in the pseudogene may be selectively advantageous, as they are more likely to disrupt the deleterious activity of the pseudogene . Human Grx1 pseudogenes have the same divergence values, indicating that they might have originated closely from the long form of human Grx1 mRNA during evolution. It has been proposed that only elements that were generated less than approximately 150 million years ago are still discernible (Brosius 1999) , in good agreement with our data.
Our findings of only processed pseudogenes in the human thioredoxin/glutaredoxin family follow the general pattern of the majority of genes with their associated pseudogenes. Processed pseudogenes are generated by mRNA copies that lack promoter sequences, so their integration is doomed to transcriptional silence unless they insert into a locus that supports their transcription. In contrast, nonprocessed pseudogenes arise from gene duplication events that are likely to include not only coding sequences, but also regulatory elements (Brosius 1999) . Therefore, there is a much higher chance that these gene duplications might lead to novel active genes than inactive pseudogenes, thus explaining the lower number of non-processed pseudogenes in any given family, including the thioredoxin/glutaredoxin family.
A recent study has pinpointed the major features for the genes that give rise to processed pseudogenes: they are widely expressed, highly conserved, short and GCpoor (Goncalves et al. 2000) , characteristics that match both Trx1 and Grx1 genes. However, this argument is not enough to explain why the rest of the thioredoxin/glutare-437 Fig. 5 Phylogenetic tree of human Trx1 (A) and human Grx1 (B) genes with their respective pseudogenes. Scale Number of substitution events per hundred bases. The numbers in parentheses show the estimated age of the pseudogene expressed as the number of million years since retrotransposition from the ancestral functional gene.
Percentage bootstrap values (based on 1000 replications) are given on the nodes of the trees doxin family members lack associated pseudogenes, as they also fulfil most of these criteria. The most likely explanation is that, for unknown reasons, the Trx1 and Grx1 loci are extremely active, generating copies of themselves and dispersing themselves all over the genome. Only in few cases has one of these copies become transcriptionally active, evolving differently from the ancestral gene but losing its capacity of generating further copies. Alternatively, the Trx1 and Grx1 genes may have been the ancestor module that generated novel forms of thioredoxinlike proteins as, throughout evolution, new adapted forms of these proteins were needed to fulfil new functions, e.g. internal fertilization (Sptrx-1 is a sperm-specific thioredoxin).
In conclusion, we have identified several putative pseudogenes derived from the known members of the human thioredoxin/glutaredoxin family of proteins. In addition, we have described an alternative splice acceptor site in the Grx1 gene; this explains the existence of two forms of Grx1 mRNA differing in the length of their respective 3'-UTRs. The human genome sequence has just been released and it will be constantly updated during the coming years. Therefore, it is possible that revised versions might slightly modify the data reported here, although the identification of novel pseudogenes is unlikely considering the homology criteria used in this study. The information reported in this work should help in the identification of novel thioredoxins and glutaredoxins, thereby facilitating rapid discrimination between functional and non-functional paralogues and providing the basis for an evolutionary record when the new mammalian genomes are sequenced.
